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BRIEF DEFINITIVE REPORT
        Naive T cells undergo diff  erentiation on signals 
received from the TCR and cytokine receptors 
and diff  erentiate to specialized subsets character-
ized by their production of signature cytokines. 
Th17 cells produce IL-17 or IL-17A and IL-17F, 
which are major mediators of infl  ammation and 
are critical for host defense against extracellular 
bacteria and fungi (  1, 2  ). IL-6, IL-21, and TGF-
    1 are critical factors that promote Th17 cell dif-
ferentiation (  1, 3  ). Although IL-23 was originally 
thought to be important for inducing naive 
CD4  +   T cells to become Th17 cells, naive CD4  +   
T cells do not express IL-23Rs (  4  ). Rather, IL-
23 is now thought to aff  ect the expansion, main-
tenance, and pathogenicity of Th17 cells (  5  ). 
IL-23 also induces IL-17 production from          
T cells and invariant NKT (iNKT) cells (  6, 7  ). 
Regardless of exactly how IL-23 works, current 
evidence clearly argues that IL-23  –  mediated 
IL-17 production is crucial in host defense and in 
the pathogenesis of autoimmune diseases (  8  –  10  ). 
  IL-6, IL-21, and IL-23 share the ability to 
activate Stat3, which was shown to be critical 
for Th17 cell diff  erentiation in mouse and man 
(  3, 11, 12  ). Stat3 directly regulates the   Il17   and 
  Il21   genes but also regulates IL-23R expression 
(  3, 12  ). Furthermore, the aforementioned cyto-
kines acting via Stat3 induce the retinoic acid  –
  related orphan receptor    t (ROR   t), the master 
regulator of Th17 cell diff  erentiation (  13  ). 
  In contrast to T cells, much less is known 
about the ability of innate cell subpopulations 
to produce IL-17. We report that splenic lym-
phoid tissue inducer  –  like cells (LTi-like cells) 
constitutively express ROR    t, IL-23R, CCR6, 
and aryl hydrocarbon receptor (AHR) (  14  ), 
and produce IL-17 and IL-22. Interestingly, 
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  The interleukin (IL) 17 family of cytokines has emerged to be critical for host defense as 
well as the pathogenesis of autoimmune and autoinfl  ammatory disorders, and serves to 
link adaptive and innate responses. Recent studies have identifi  ed a new subset of T cells 
that selectively produce IL-17 (Th17 cells; Bettelli, E., T. Korn, and V.K. Kuchroo. 2007. 
  Curr. Opin. Immunol.   19:652  –  657; Kolls, J.K., and A. Linden. 2004.   Immunity.   21:467  –
  476), but the regulation of IL-17 production by innate immune cells is less well under-
stood. We report that in vitro stimulation with IL-23 induced IL-17 production by 
recombination activating gene (Rag) 2      /      splenocytes but not Rag2      /      common      chain      /      
splenocytes. We found that a major source of IL-17 was CD4  +  CD3       NK1.1       CD11b       Gr1       CD
11c       B220        cells, a phenotype that corresponds to lymphoid tissue inducer  –  like cells (LTi-
like cells), which constitutively expressed the IL-23 receptor, aryl hydrocarbon receptor, 
and CCR6. In vivo challenge with the yeast cell wall product zymosan rapidly induced IL-
17 production in these cells. Genetic deletion of signal transducer and activator of tran-
scription 3 reduced but did not abrogate IL-17 production in LTi-like cells. Thus, it appears 
that splenic LTi-like cells are a rapid source of IL-17 and IL-22, which might contribute to 
dynamic organization of secondary lymphoid organ structure or host defense. 
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with IL-23 had no eff  ect on IL-17A production; however, 
IL-4 suppressed IL-23  –  induced IL-17A production by WT 
and Rag2      /      splenocytes (Fig. S1 A, available at http://www
.jem.org/cgi/content/full/jem.20072713/DC1). In addition 
to memory CD4  +   T cells, iNKT cells are another important 
source of IL-17 (  7  ), but such cells are lacking in Rag2      /      
mice. Accordingly, anti-CD3/28 or     -galactosylceramide 
(    -GalCer) stimulation induced IL-17A production by WT 
splenocytes but not Rag2      /      splenocytes (Fig. S1, B and C). 
Collectively, these data suggest that although T and NKT 
cells are both major producers of IL-17, populations of non  –  T, 
non  –  B cells can also produce IL-17. 
  To identify which population of cells might be responsible 
for IL-23  –  dependent IL-17 production by Rag2      /      spleno-
cytes, we examined another genetic model, namely Rag2      /   
      c      /      mice. In addition to lacking T and B cells, Rag2      /         c      /      
mice also lack NK cells. We therefore cultured WT, Rag2      /     , 
or Rag2      /         c      /      splenocytes in the presence of IL-23. Con-
sistent with   Fig. 1 A  , IL-17A production was present in WT 
splenocytes and reduced but not absent in Rag2      /      splenocytes 
(  Fig. 1 B  ). In contrast, IL-17A production by Rag2      /         c      /      
splenocytes was essentially abrogated (  Fig. 1 B  ). These results 
indicate that     c-dependent, non  –  T, non  –  B cell populations in 
the spleen can produce IL-17 in vitro. 
  IL-23 has been shown to be induced by certain microbial 
products (  15  ). Rag2      /      mice were therefore injected with 
zymosan to induce IL-23 production by DCs, which resulted 
in rapid IL-17A appearance in sera and spleens (  Fig. 1 C  ). 
Thus, these data indicate that innate immune cells can gener-
ate IL-17 in response to the fungal product in vivo. 
  IL-17 production by CD4  +  CD3       CD11c       B220        LTi-like cells 
  To delineate the population of IL-17  –  producing cells, we 
next used intracellular cytokine staining. We used markers 
for a variety of innate immune cells expected to be present 
in Rag2      /      spleens but failed to detect IL-23  –  mediated 
IL-17A production in granulocytes, macrophages, or DCs 
(Fig. S2, available at http://www.jem.org/cgi/content/full/jem
.20072713/DC1). A prominent     c-dependent lineage that 
rapidly produces cytokines upon stimulation is the NK cell. 
Based on the response to IL-23 in Rag2      /      splenocytes and 
loss in Rag2      /         c      /      splenocytes, we thought that NK cells 
could be IL-17 producers. However, contrary to our expec-
tations, the majority of IL-17A  –  producing CD3        cells did 
not express NK1.1 (  Fig. 2 A  ).   Thus far, our results have indi-
cated that neither T, NKT, NK cells (all     c dependent) 
nor     c-independent myeloid cells were a major source of 
IL-17 production in Rag2      /      spleens. We did observe that in 
Rag2      /      splenocytes stimulated with IL-23 (  Fig. 2 B  , left), a 
considerable proportion of the IL-17A  –  producing non  –  T 
cells expressed CD4 (  Fig. 2 B  , right). 
  CD4  +  CD3        cells in the Rag2      /      spleen comprise three 
populations, including CD11C  low  B220  +   plasmacytoid DCs, 
CD11C  +  B220        conventional DCs, and CD4  +  CD3       CD11c      
B220        cells (Fig. S3, available at http://www.jem.org/cgi/
content/full/jem.20072713/DC1). As indicated in Fig. S2, 
the yeast wall product zymosan elicited IL-17 production by 
LTi-like cells in vivo. Whether the production of IL-17 and 
IL-22 infl  uences the architecture of secondary lymphoid or-
gans (SLOs) and contributes to host defense will be important 
issues to examine in the future. 
    RESULTS AND DISCUSSION   
  IL-23 induces IL-17 production by a population 
of common      chain (    c)  –  dependent non  –  T, non  –  B cells 
  To determine if there are considerable proportions of innate 
immune cells that produce IL-17, we examined Rag2      /      
mice that have few T and B cells. We fi  rst assessed whether 
IL-17 production occurred in Rag2      /      splenocytes after 
stimulation with various cytokines. As shown in   Fig. 1 A  , IL-
23 alone induced IL-17A production by WT splenocytes, 
presumably indicative of an eff  ect on memory T cells.   Con-
sistent with the idea that memory T cells are lacking in 
Rag2      /      mice, the eff  ect of IL-23 was reduced in Rag2      /      
splenocytes (  Fig. 1 A  ). However, Rag2      /      splenocytes still 
produced about one third as much IL-17A as WT splenocytes 
(  Fig. 1 A  ). Other cytokines used separately or in combination 
    Figure 1.         IL-23 and zymosan induce IL-17 production in a popu-
lation of non  –  B, non  –  T cells.   (A) WT or Rag2     /     splenocytes were cul-
tured in the presence of the indicated cytokines for 48 h, and IL-17A in 
culture supernatants was measured by ELISA. The data are means   ±   SD 
from duplicate cultures and are representative of four independent ex-
periments (  n   = 8). **, P   <   0.01. (B) WT, Rag2     /    , or Rag2     /     c    /     spleno-
cytes were cultured in the presence of IL-23 alone, and IL-17A in culture 
supernatants was measured by ELISA. The data are means   ±   SD from 
duplicate cultures and are representative of three independent experi-
ments (  n   = 6). *, P   <   0.05; **, P   <   0.01. (C) Sera and splenocytes were har-
vested from Rag2     /     mice after injection of 5 mg zymosan or PBS 
(Control). (left) IL-17A in sera was measured by ELISA. (right) The relative 
expression levels (/18S) of IL-17A mRNA were analyzed by quantitative 
PCR (q-PCR) and are depicted as fold induction relative to cells 1 h after 
treatment with zymosan. The data are means   ±   SD of results from two 
mice per group per time point and are representative of two independent 
experiments. ND, not detected.     JEM VOL. 206, January 19, 2009  37
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to maintain cells for the initial 48 h, followed by IL-23 for an-
other 6 h. As shown in Fig. S7 A, IL-17A and IL-17F mRNA 
expression was potently induced by IL-23 in the presence of 
IL-7. These results suggest that LTi-like cells quickly enhance 
the production of IL-17 in response to IL-23, and this cyto-
kine does not simply serve to keep these cells alive. 
  It is well known that Stat3 is activated by IL-23 and other 
inducers of Th17 cell diff  erentiation, and the absence of Stat3 
abrogates IL-17 production by T cells (  12  ). We therefore as-
sessed the proportion of IL-17A  –  producing LTi-like cells in 
Stat3-defi  cient mice. Not surprisingly, we found that IL-23  –
  mediated IL-17A production was decreased in Stat3-defi  cient 
LTi-like cells of   Stat3  fl / fl   ; MMTV-Cre   or   Stat3  fl  /fl    ; CD4-Cre   
splenocytes compared with those of   Stat3  fl / fl      splenocytes, al-
though IL-17A production was not completely abrogated 
(  Fig. 3 B   and not depicted). Because Cre-mediated deletion 
of STAT3 is   >  90% in both systems (unpublished data), there 
seems to be both STAT3-dependent and -independent path-
ways for the production of IL-17 in LTi-like cells. We also 
observed that IL-23 up-regulated mRNA expression of Stat3 
and Stat4 but not GATA3 in LTi-like cells (Fig. S7 B). These 
results highlight the notion that the IL-17 production by 
LTi-like cells might be dependent on these factors. 
  LTi-like cells constitutively express IL-23R, AHR, and CCR6 
  The complete receptor for IL-23 comprises the IL-12R    1 
associated with the ligand-specifi  c subunit IL-23R, and both 
subunits are required for the action of this cytokine (  4  ). As 
memory CD4  +   T cells respond to IL-23 because of constitu-
tive expression of its receptors (  4  ), we evaluated mRNA 
expression of IL-23R and IL-12R    1 in LTi-like cells. 
Consistent with their rapid responsiveness to IL-23, LTi-like 
cells constitutively expressed IL-23R mRNA at levels sig-
nifi  cantly greater than T cells (  Fig. 3 C  ). LTi-like cells also 
expressed slightly higher levels of IL-12R    1 mRNA com-
pared with those of memory CD4  +   T cells (  Fig. 3 C  ). In 
contrast, expression levels of IL-12R    2 mRNA in LTi-like 
cells were low compared with those in memory CD4  +   T 
cells (  Fig. 3 C  ). Also consistent with previous studies (  16, 18  ), 
we noted higher expression levels of ROR    t mRNA in 
LTi-like cells compared with T cells (  Fig. 3 C  ). In contrast, 
expression of IL-6R     and IL-17RA mRNA in LTi-like 
cells was much lower compared with that in T and B cells 
(unpublished data). Recently, the AHR has been reported to 
be expressed in Th17 cells (  14  ). Interestingly, LTi-like cells 
also expressed AHR mRNA at levels equivalent to those in 
Th17 cells polarized for 72 h (  Fig. 3 C  ). Furthermore, IL-23 
up-regulated mRNA expression levels of IL-23R, ROR    t, 
and AHR (Fig. S7 C). 
  Consistent with previous studies (  16, 18  ), splenic LTi-like 
cells were found to be CD30L +  OX40L  +      c  +  IL-7R      +  Thy1.2  high
  CD44  high  CD62L  low   (Fig. S6). LTi-like cells are also known 
to express the chemokine receptors CXCR5  +   and CCR7  +   
(  16, 18  ), and we again confi  rmed expression of these in the 
splenic LTi-like cells (Fig. S6). Additionally, it has recently 
been shown that CCR6 identifi  es a population of human 
we did not detect IL-23  –  mediated IL-17A production by 
CD11C  +   DC populations. The latter, CD4  +  CD3       CD11c      
B220        cells, have been shown to be present in SLOs of fetal 
and adult mice and are termed LTi  ’  s and LTi-like cells, re-
spectively (  16  ). Importantly, LTi-like cells are greatly reduced 
in     c      /      mice (  17  ). 
  We next determined whether isolated CD4  +  CD3      
CD11c       B220        LTi-like subsets produced IL-17 (  Fig. 3 A  , 
top).   In fact, as shown in   Fig. 3 A   (bottom), we observed IL-17A 
production by isolated LTi-like cells in response to IL-23. 
Moreover, directly isolated LTi-like cells produced more 
IL-17A in the presence of PMA/ionomycin (Iono), which 
was dramatically enhanced by IL-23 (  Fig. 3 A  , bottom). In 
contrast, LTi-negative subsets produced minimal IL-17A 
(Fig. S4, available at http://www.jem.org/cgi/content/full/
jem.20072713/DC1). Consistent with Fig. S2, isolated CD11c  +   
cells did not produce IL-17A with IL-23 stimulation (unpub-
lished data). Another source of LTi-like cells in an adult 
mouse is the intestinal lamina propria (  16  ). Interestingly, 
LTi-like cells in the lamina propria from WT mice produced 
IL-17A after stimulation with PMA/Iono (Fig. S5). These 
results suggest that the ability to produce IL-17 is not unique 
to the splenic population. 
  One possible explanation for our observations is that IL-23 
promoted in vitro survival of LTi-like cells rather than en-
hancing IL-17 production by itself. LTi-like cells have been 
shown to express IL-7Rs (Fig. S6, available at http://www
.jem.org/cgi/content/full/jem.20072713/DC1) (  16  ). There-
fore, we modifi  ed the cell-culture conditions by adding IL-7 
    Figure 2.         CD4  +  CD3       lineage        cells produce IL-17.   Rag2    /     spleno-
cytes were cultured in the absence (Control) or presence of IL-23 for 24 h. 
The proportion of IL-17A  –  producing CD3        cells was evaluated by intra-
cellular staining. (A) NK1.1  +   versus  IL-17A +   cells gated on CD3        cells  are 
shown. (B) IL-17A  +   versus  CD3 +   cells (nongated; left) and IL-17A  +   versus 
CD4  +   cells gated on CD3        cells (right) are shown. Data are representative 
of three independent experiments.     38 IL-17 AND IL-22 PRODUCTION BY SPLENIC LT  I  -LIKE CELLS   | Takatori et al. 
tion of IL-17A  –  producing LTi-like cells was determined by 
FACS. As shown in   Fig. 4   (top) the proportion of IL-17  –
  producing LTi-like cells was signifi  cantly greater in zymo-
san-treated mice compared with control mice.   To further 
establish the ability of LTi-like cells to produce IL-17 in 
vivo, we treated Rag2      /      mice with BFA i.v. (  21  ) and chal-
lenged them with zymosan i.p. for 6 h. We observed few IL-
17A  –  producing LTi-like cells in control mice, whereas 
zymosan-treated mice had a signifi  cant increase in IL-17A  –
  producing cells (  Fig. 4  , bottom). These results establish that 
LTi-like cells can rapidly produce IL-17 in vivo when chal-
lenged with the product of fungal pathogens. 
  LTi-like cells also produce IL-22 
  It has been argued that Th17 cells also preferentially produce 
IL-22 (  22  ). Interestingly, we found that treatment with zymo-
san induced not only IL-17A but also IL-22 in the sera and 
spleens of Rag2      /      mice (  Fig. 5 A  ).   In vitro stimulation with 
memory CD4  +   T cells that selectively produce IL-17 (  19  ), we 
found that most of the splenic LTi-like cells express CCR6 
(  Fig. 3 D  ). Approximately half of the CCR6  +   LTi-like cells 
coexpressed CXCR5 and CCR7 (unpublished data), suggest-
ing that the expression of those chemokine receptors on LTi-
like cells is heterogeneous, as previously reported (  20  ). On the 
other hand, the expression of CXCR3, CCR5, or CCR4, 
which are preferentially expressed on Th1 or Th2 cells (  19  ), 
was low on splenic LTi-like cells (Fig. S6 and not depicted). 
  LTi-like cells produce IL-17 during zymosan-induced 
infl  ammation in Rag2      /      mice 
  We next determined whether LTi  -  like cells produced IL  -  17 
in vivo in an infl   ammatory setting. We approached this 
problem in two ways: fi  rst, we injected Rag2      /      mice with 
zymosan i.p. to induce infl  ammation and harvested spleno-
cytes 2 h later. The cells were then stimulated ex vivo with 
PMA/Iono and Brefeldin A (BFA) for 2 h, and the propor-
    Figure 3.         Isolated CD4  +  CD3       CD11c       B220        LTi-like cells produce IL-17 and constitutively express IL-23R, ROR    t, AHR, and CCR6.   (A) Iso-
lated CD4  + CD3     CD11c     B220       LTi-like subsets from Rag2     /     splenocytes (top) were cultured in the absence (Control) or presence of IL-23 (or with PMA/
Iono) for 24 h, and IL-17A in culture supernatants was measured by ELISA (bottom). Data are means   ±   SD from duplicate cultures and are representative 
of two independent experiments. (B)   Stat3  fl  /fl      or   Stat3  fl  /fl   ; MMTV-Cre   splenocytes were cultured in the absence (Control) or presence of IL-23 for 24 h. The 
proportion of IL-17A  –  producing LTi-like cells was evaluated by intracellular staining. Data are means   ±   SD from duplicate cultures and are representative 
of four independent experiments (  n   = 8). *, P   <   0.05. (C) Total RNA was prepared from LTi-like cells isolated from Rag2     /     spleens. The relative expression 
levels (/18S) of the indicated mRNA was analyzed by q-PCR and are depicted as fold induction relative to fresh B cells (or fresh naive T cells for AHR 
mRNA expression). Data are representative of three independent experiments. M-T, memory T cells; N-T, naive T cells. (D) The expression of CCR6 on LTi-
like cells of WT splenocytes was analyzed by FACS. The shaded histogram indicates staining with isotype-matched control antibodies. The continuous line 
histogram indicates the surface expression level of CCR6 on LTi-like cells. Data are representative of three independent experiments. ND, not detected.     JEM VOL. 206, January 19, 2009  39
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it is becoming increasingly clear that they are not the only 
source of IL-17. Clearly,          T and iNKT cells produce IL-17 
to protect against bacterial infection (  6, 7  ). In addition, a re-
cent study provides evidence that IL-23 can drive IL-17 
production by innate immune cells in animal models of in-
fl  ammatory bowel disease (  23  ). 
  We were very impressed by the loss of IL-17 production 
in Rag2      /         c      /      mice (  Fig. 1 B  ). We initially suspected that 
this pointed to production of IL-17 by NK cells but were sur-
prised by the failure to see IL-17 production by NK1.1  +  CD3        
NK cells (  Fig. 2 A  ). However, LTi-like cells are also depen-
dent on     c cytokines for development (  17  ). Before our stud-
ies, it was known that these cells expressed ROR    t, which 
was required for their function in LNs (  16, 18  ). ROR    t has 
several important functions, but it is now clear that one func-
tion is the regulation of Th17 cell diff  erentiation (  13  ). We 
confi   rmed that splenic LTi-like cells constitutively express 
ROR    t (  Fig. 3 C  ) and that IL-23 further up-regulated its ex-
pression (Fig. S7 C), arguing that this factor is essential in 
controlling IL-17 and IL-22 production by non  –  T cells. In-
terestingly, fresh LTi-like cells also constitutively expressed 
more AHR than polarized Th17 cells (  Fig. 3 C  ). LTi-like 
cells also constitutively expressed IL-23R and CCR6 (  Fig. 3, 
C and D  ), similar to CCR6  +  IL-23R  +   human memory CD4  +   
T cells, which are major producers of IL-17 (  19, 24  ). Thus, 
the expression of ROR    t, AHR, CCR6, and IL-23R seems 
to be the signature to defi  ne IL-17  –   and IL-22  –  producing 
cells in both adaptive and innate immune cells. 
  LTi-like cells are involved in the proper formation of pe-
ripheral LNs, the spleen, and gut-associated lymphoid tissue 
by highly expressing lymphotoxin     , lymphotoxin     , and 
TNF-     (  16, 25  ). Our data indicate that splenic and gut LTi-
like cells also produce IL-17 and IL-22 (  Figs. 3 A and 5 B  ; 
and Fig. S7, A and D) (  26  ). It has been recently shown that 
blocking IL-17 results in disruption of the germinal center  –
  like formation in the spleen, and restoration of the lymphoid 
microanatomy is dependent on the proliferative accumula-
tion of LTi-like cells in SLOs during viral infection (  27, 28  ). 
In addition, the cross talk between bacteria, LTi cells, stromal 
cells, DCs, and B cells seems to be essential for isolated lym-
phoid follicle formation in the gut (  29  ). LTi-like cells might 
IL-23 induced more IL-22 production by Rag2      /      spleno-
cytes than WT splenocytes (  Fig. 5 B  ). Furthermore, isolated 
LTi-like cells also produced IL-22 (  Fig. 5 B   and Fig. S7 D). 
Although we observed that NK1.1  +  CD3        NK cells failed to 
produce IL-17A (  Fig. 2 A  ), isolated NK cells produced small 
amounts of IL-22 in response to IL-23 (Fig. S8, available at 
http://www.jem.org/cgi/content/full/jem.20072713/DC1). 
These fi  ndings illustrate the potentially distinct modes of reg-
ulation for IL-17 and IL-22. 
  The IL-23  –  IL-17 axis has emerged to be important in 
host defense and in models of autoimmunity such as experi-
mental autoimmune encephalomyelitis and infl  ammatory 
bowel disease (  10, 23  ). Despite the importance of Th17 cells, 
    Figure 4.         Zymosan induces IL-17 production in splenic LTi-like 
cells in vivo.   (left) Intracellular staining of IL-17A was performed with in 
vitro conventional staining (top) or in vivo staining (bottom). For conven-
tional staining, Rag2     /     mice were challenged with PBS (Control) or 12.5 
mg zymosan i.p. Splenocytes were isolated 2 h later and stimulated with 
PMA/Iono and BFA for 2 h in vitro. The proportion of IL-17A  –  producing 
LTi-like cells was evaluated by intracellular staining. For the in vivo stain-
ing, Rag2     /     mice were injected with PBS (Control) or 12.5 mg zymosan 
i.p. together with 0.25 mg BFA i.v. (reference   22  ). The proportion of IL-17A  –
  producing LTi-like cells in spleens was directly evaluated by intracellular 
staining. (right) The mean values (horizontal bars) for IL-17A  –  producing 
LTi-like cells were calculated for in vitro staining (top,   n   = 6) and in vivo 
staining (bottom,   n   = 6). Data are representative of three (top) or two 
(bottom) independent experiments. ***, P   <   0.001.     
    Figure 5.         LTi-like cells produce high levels of IL-22.   (A) Sera and splenocytes were harvested from Rag2     /     mice 3 h after injection of PBS (Control) 
or 5 mg zymosan. (left) IL-22 in sera was measured by ELISA. (right) The relative expression levels (/18S) of IL-22 mRNA were determined by q-PCR and 
are depicted as fold induction relative to control cells. The data are means   ±   SD from two mice and are representative of two independent experiments. 
(B) WT or Rag2     /     splenocytes or isolated LTi-like cells were cultured in the presence of IL-23 for 24 h, and IL-22 in culture supernatants was measured 
by ELISA. The data are means   ±   SD from duplicate cultures and are representative of two independent experiments.     40 IL-17 AND IL-22 PRODUCTION BY SPLENIC LT  I  -LIKE CELLS   | Takatori et al. 
CD4  +  CD3  +  CD62L       CD44  +   memory T cells; CD4  +  CD3  +  CD62L  high  CD44  low   
naive T cells; CD19  +   B cells, Th17 cells polarized with IL-6, TGF    -1, and 
anti-CD3/-CD28 for 3 d; and CD4  +  CD3       CD11c       B220        LTi-like cells. 
cDNA was synthesized with the TaqMan Reverse Transcription kit (Ap-
plied Biosystems). TaqMan primers and probes for mouse IL-17A, IL-17F, 
IL-22, IL-23R, IL-12R    1, IL-12R    2, RORc (for ROR    t), IL-17RA, 
IL-6R    , CCR6, AHR, GATA3, and 18SrRNA (as endogenous control) were 
purchased from Applied Biosystems. Samples were analyzed by using a se-
quence detection system (ABI PRISM 7700; Applied Biosystems). 
  The amounts of cytokines in the culture supernatant were measured us-
ing mouse IL-17 Quantikine assay kits (for IL-17A; R  &  D Systems) and the 
mouse IL-22 ELISA construction kit (Antigenix America Inc.) according to 
the manufacturers  ’   instructions. IL-23  –  mediated cell stimulations were per-
formed at cell concentrations of 4   ×   10  6   cells/ml. Samples were measured in 
duplicate against the standard curve of the assay. 
  Data analysis.     Statistical signifi  cance was determined by the Student  ’  s   t   test. 
P   <   0.05 was considered to indicate a signifi  cant diff  erence. 
  Online supplemental material.     Fig. S1 shows IL-17A production by WT 
or Rag2      /      splenocytes in the presence of IL-23 with     c-dependent cyto-
kines, anti-CD3/-CD28, or    -GalCer. Fig. S2 shows that IL-17A –  producing 
CD3        cells do not express myeloid markers. Fig. S3 shows three populations 
in CD4  +  CD3        cells from Rag2      /      spleens. Fig. S4 shows that LTi-negative 
subsets produce minimal IL-17A. Fig. S5 shows IL-17A production by LTi-
like cells in the gut. Fig. S6 shows the surface expression of various markers 
on LTi-like cells. Fig. S7 shows mRNA expression of various factors in LTi-
like cells after IL-23 stimulation with IL-7. Fig. S8 shows IL-22 and IL-17A 
production by isolated NK cells. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20072713/DC1. 
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